Widely used blood pressure medication recalled nationwide
Federal health officials warn that a widely used blood pressure medication recalled nationwide could contain a superpotent element. The action affects over 21,000 bottles of hypertension treatment involved in the current safety alert. Patients who take the medication are advised to check their product labels carefully. Medical experts caution individuals not to discontinue their treatment regimen without first consulting a qualified healthcare professional. This safety notice follows previous regulatory actions involving blood pressure medications earlier in the year.
Listen to Live Briefing
Real-time synthesized voice briefing Β· Live Feeds Desk
- β FDA officials stated there is a chance the recalled blood pressure medication could contain a superpotent element.
What changed
Federal officials announced that the recalled medication may contain a superpotent element.
Live updates
-
Nationwide Blood Pressure Medication Recall Expands
Federal health officials warn that a widely used blood pressure medication recalled nationwide could contain a superpotent element. The action affects over 21,000 bottles of hypertension treatment involved in the current safety alert. Patients who take the medication are advised to check their product labels carefully. Medical experts caution individuals not to discontinue their treatment regimen without first consulting a qualified healthcare professional. This safety notice follows previous regulatory actions involving blood pressure medications earlier in the year.
Why it matters
Drug recalls disrupt patient treatment routines and require urgent communication between pharmacies and consumers. Safety warnings regarding potency issues pose direct risks to patient health if dosages deviate from prescribed levels. Regulatory monitoring tracks these pharmaceutical defects to prevent adverse medical events.
What is confirmed
- FDA officials stated there is a chance the recalled blood pressure medication could contain a superpotent element.
Still unconfirmed
- Specific lot numbers and distribution channels for the newly reported superpotent bottles remain unspecified in the current update.
What to watch next
- Additional FDA announcements regarding affected lot numbers
- Guidance from medical associations on patient switching protocols
confidence 90%Sources used for this update (3)
- www.cpsc.gov β Recalls & Product Safety Warnings | CPSC.gov
- medivascan.com β Drug recalls, by class and condition - MedivaScan
- www.thehealthy.com β Blood Pressure Drug Recall: More Than 21,000 Bottles Involved ...
-
FDA Recalls 13,567 Bottles of Chlorthalidone Blood Pressure Tablets
The FDA issued a Class II recall for 13,567 bottles of 25-milligram chlorthalidone tablets because they failed dissolution testing. This marks the second recall for these tablets this year, bringing the total affected volume to over 25,027 bottles. Patients should verify their medication labels but must not stop treatment without consulting a medical professional. Separate from this, Dr Reddy's Laboratories Ltd recalled 13,560 bottles of metoprolol succinate, another hypertension medication, in June.
Why it matters
Dissolution testing ensures medication dissolves at the correct rate to be absorbed by the body. Failure in these tests can affect the drug's efficacy. This recall is part of a broader pattern of quality flaws affecting medicines from Indian pharmaceutical companies in the US.
What is confirmed
- A Class II recall affects 13,567 bottles of 25-milligram chlorthalidone tablets due to dissolution testing failure.
- Two recalls of chlorthalidone tablets this year have affected more than 25,027 bottles.
- Dr Reddy's Laboratories Ltd recalled 13,560 bottles of metoprolol succinate in the United States in June.
Still unconfirmed
- Indian pharmaceutical giants are recalling medicines in the US due to quality flaws.
What to watch next
- FDA publication of specific lot numbers for the chlorthalidone recall
- Further quality audit results for Indian pharmaceutical manufacturers operating in the US
confidence 90%Sources used for this update (12)
- indiawest.com β FDA: Indian Pharma Giants Will Recall Medicines In US Over Quality ...
- drugrecallcheck.com β Check if your medication has been recalled | US Drug Recall ...
- medivascan.com β Blood pressure medication recalls | MedivaScan
- recallbench.com β Is it recalled? Search every U.S. recall by product, lot code ...
- www.breitbart.com β pharmaceuticals Articles - Breitbart
- www.medicaldaily.com β RAPTURE Preworkout Recalled Nationwide Five Months After FDA ...
- morningoverview.com β RAPTURE preworkout powder is recalled nationwide over DMAA, a ...
- www.fda.gov β Par Health Issues Voluntary Nationwide Recall of Two Lots of ...
- www.foxbusiness.com β CVS Pharmacy reaches $315M settlement with Justice Department over controlled substance prescriptions - F....
- www.foxbusiness.com β Great Business Leaders in America & Around the World | Fox Business
- www.yahoo.com β Over 112,000 Bottles of Popular Pain Reliever Recalled Nationwide After Consumer Complaints
- toledolaw.com β Dr Reddyβs Recalls Generic Hypertension Drug | Zoll & Kranz
-
Nationwide recall issued for chlorthalidone tablets
A Class II recall has been issued for 13,567 bottles of 25-milligram chlorthalidone tablets due to failure in dissolution testing. This is the second recall of these tablets this year, affecting over 25,027 bottles. Patients are advised to check their labels but not stop taking the medication without medical guidance.
Why it matters
The recall was issued due to concerns over the quality of the medication. Chlorthalidone is a widely used blood pressure medication. The recall affects patients who rely on this medication to manage their condition. The manufacturer, Inventia Healthcare Ltd., has issued the recall to ensure patient safety.
What is confirmed
- A nationwide Class II recall has been issued for 13,567 bottles of 25-milligram chlorthalidone tablets manufactured by Inventia Healthcare Ltd. due to failure in dissolution testing.
- This is the second recall of these tablets this year, bringing the total number of affected bottles to over 25,027.
What to watch next
- Further updates on the recall and its impact on patients
- Actions taken by regulatory agencies in response to the recall
- Guidance from healthcare professionals on alternative treatments
confidence 100%Sources used for this update (3)
- www.dictionary.com β WIDELY Definition & Meaning | Dictionary.com
- en.wiktionary.org β widely - Wiktionary, the free dictionary
- www.vocabulary.com β Widely - Definition, Meaning & Synonyms | Vocabulary.com
-
Nationwide Recall Issued for Chlorthalidone Tablets
A nationwide Class II recall has been issued for 13,567 bottles of 25-milligram chlorthalidone tablets manufactured by Inventia Healthcare Ltd. due to failure in dissolution testing. This is the second recall of these tablets this year, bringing the total number of affected bottles to over 25,027. Patients taking the medication are advised to check their labels but not stop taking it without medical guidance.
Why it matters
Chlorthalidone tablets are used to treat high blood pressure, heart failure, kidney disease, and cirrhosis. The recall was issued by the FDA after the tablets failed to dissolve properly, which can affect their efficacy and safety. This recall affects patients relying on the medication for chronic conditions.
What is confirmed
- The recall affects 13,567 bottles of 25-milligram chlorthalidone tablets.
- This is the second recall of these tablets this year, totaling over 25,027 affected bottles.
- Patients taking the medication are advised to check their labels but not stop taking it without medical guidance.
What to watch next
- Further updates from the FDA on additional recalls or safety alerts
- Reports from patients or healthcare providers on the impact of the recalled medication
- Actions taken by Inventia Healthcare Ltd. to rectify the manufacturing issue
confidence 100%Sources used for this update (6)
- www.foxbusiness.com β Product Recalls
- www.medicaldaily.com β Federal Jury Convicts Michigan Doctor of Distributing More Than 2 Million Stimulant Pills Through Done's ....
- www.medicaldaily.com β Heart Failure Contributed to 452,573 U.S. Deaths in 2023 as Report Flags Rising Death Rates in Younger Ad....
- www.indiaweekly.biz β Kiara Advani, Deepika Padukone are choosing 'two under three': Why are more urban women choosing closer pregnancies?
- dictionary.cambridge.org β WIDELY | English meaning - Cambridge Dictionary
- dictionary.cambridge.org β WIDELY | definition in the Cambridge English Dictionary
-
FDA Issues Class II Recall for Inventia Healthcare Blood Pressure Medication
The FDA has issued a nationwide Class II recall for 13,567 bottles of 25-milligram chlorthalidone tablets manufactured by India-based Inventia Healthcare Ltd. The recall follows the discovery that the tablets failed dissolution testing, meaning they do not dissolve properly. This marks the manufacturer's second recall of these tablets this year, bringing the total number of affected bottles to over 25,027. Patients taking the medication for blood pressure, heart failure, kidney disease, or cirrhosis are advised to check their labels, though they should not stop taking the medication without medical guidance.
Why it matters
Chlorthalidone is a diuretic used to treat hypertension and related conditions. A Class II designation indicates a situation where use of the product may cause temporary or medically reversible adverse health consequences. The failure of dissolution specifications can impact how the drug is absorbed into the bloodstream.
What is confirmed
- Inventia Healthcare Ltd. initiated a voluntary recall of 13,567 bottles of 25-milligram chlorthalidone tablets.
- The tablets failed FDA dissolution testing.
- The FDA designated the recall as Class II.
- Over 25,000 bottles of the medication have been affected by recalls from this manufacturer this year.
- The affected medication is a diuretic used for blood pressure.
Still unconfirmed
- The recalled pills may have been prescribed to patients with heart failure, kidney disease, or cirrhosis of the liver.
- Lot RISA24002 is among the affected products.
What to watch next
- FDA announcement of any further recall classification upgrades to Class I
- Publication of a complete list of all affected lot numbers
- Reports of adverse patient reactions linked to the dissolution failure
confidence 95%Sources used for this update (23)
- www.foxbusiness.com β Health Care
- WUSA9 β Blood pressure medication recalled nationwide after failing FDA dissolution testing
- newsnationnow.com β Blood pressure medication given Class II designation in recall update
- USA Today β Blood pressure medication recalled nationwide. See affected drug
- www.usatoday.com β Blood pressure medication recalled. See affected product
- ground.news β Blood pressure medication recalled nationwide under FDAβs ...
- Fox Business β Widely used blood pressure medication recalled nationwide
- NBC 5 Dallas-Fort Worth β FDA recalls more than 13k bottles of blood pressure medication after quality issue
- flipboard.com β FDA Updates Recalled Blood Pressure Medication to Second-Highest Level
- www.yahoo.com β Blood pressure medication recalled nationwide. Check ... - Yahoo
- www.yahoo.com β Widely used blood pressure medication recalled nationwide
- www.newsbreak.com β Trump Accounts will auto-enroll children, potentially adding 60 million accounts: Treasury - NewsBreak
Community Sentiment: How do you assess this situation?
Voice your perspective Β· Real-time aggregated sentiment from the Live Feeds community